Table 2.
Univariate analysis: factors predicting overall surviva
| Characteristic | N | Overall survival | |
|---|---|---|---|
|
| |||
| P value | Hazard Ratio (95% CI) | ||
| FIGO stage | |||
| I~II | 56 | <0.001 | 19.83 (1.18-40.62) |
| III~IV | 44 | ||
| Histologic type | |||
| Serous carcinoma | 60 | NS | 5.21 (0.5-10.89) |
| Mucinous carcinoma | 13 | ||
| Endometrioid carcinoma | 15 | ||
| Clear cell carcinoma | 10 | ||
| Others | 2 | ||
| Histologic grade | |||
| Grade 1 | 23 | 0.008 | 15.57 (1.00-33.16) |
| Grade 2 | 29 | ||
| Grade 3 | 48 | ||
| Residual tumor size | |||
| <1 cm | 64 | NS | 4.28 (0.67-8.71) |
| ≥1 cm | 36 | ||
| Chemoresistance | NS | 7.09 (0.82-14.20) | |
| Yes | 37 | ||
| No | 63 | ||
| Recurrence | NS | 8.15 (0.89-17.36) | |
| Yes | 54 | ||
| No | 46 | ||
| miR-200a status | |||
| High | 53 | <0.001 | 22.69 (1.32-50.53) |
| Low | 47 | ||
| miR-200b status | |||
| High | 50 | <0.001 | 20.28 (1.20-42.28) |
| Low | 50 | ||
| miR-200c status | |||
| High | 52 | <0.001 | 21.42 (1.26-48.33) |
| Low | 48 | ||